Published on in Vol 5, No 3 (2016): Jul-Sept
Journals
- Matsumura W, Fujita Y, Shinkuma S, Suzuki S, Yokoshiki S, Goto H, Hayashi H, Ono K, Inoie M, Takashima S, Nakayama C, Nomura T, Nakamura H, Abe R, Sato N, Shimizu H. Cultured Epidermal Autografts from Clinically Revertant Skin as a Potential Wound Treatment for Recessive Dystrophic Epidermolysis Bullosa. Journal of Investigative Dermatology 2019;139(10):2115 View
- Masuoka H, Morimoto N, Mahara A, Sakamoto M, Mitsui T, Kakudo N, Kusumoto K, Yamaoka T. Simple and efficient method for consecutive inactivation–cryopreservation of porcine skin grafts. Journal of Artificial Organs 2020;23(2):147 View
- Gu C, Wang X, Luo X, Liu F, Zhou X, Yang J, Yang Q, Wang X. An alternative strategy treated giant congenital melanocytic nevi with epidermis and superficial dermis of the lesions. Medicine 2018;97(4):e9725 View
- Lucich E, Rendon J, Valerio I. Advances in Addressing Full-Thickness Skin Defects: A Review of Dermal and Epidermal Substitutes. Regenerative Medicine 2018;13(4):443 View
- Meshram G, Kaur N, Hura K. Giant Congenital Melanocytic Nevi: An Update and Emerging Therapies. Case Reports in Dermatology 2018;10(1):24 View
- Jinno C, Morimoto N, Mahara A, Sakamoto M, Ogino S, Fujisato T, Suzuki S, Yamaoka T. Extracorporeal high-pressure therapy (EHPT) for malignant melanoma consisting of simultaneous tumor eradication and autologous dermal substitute preparation. Regenerative Therapy 2020;15:187 View
- Le T, Morimoto N, Ly N, Mitsui T, Notodihardjo S, Munisso M, Kakudo N, Moriyama H, Yamaoka T, Kusumoto K. Hydrostatic pressure can induce apoptosis of the skin. Scientific Reports 2020;10(1) View
- Matsuura Y, Sakamoto M, Ogino S, Arata J, Morimoto N, Maruccia M. Inactivated Nevus Tissue with High Hydrostatic Pressure Treatment Used as a Dermal Substitute after a 28-Day Cryopreservation Period. BioMed Research International 2021;2021:1 View
- Im S, Yamanaka H, Tsuge I, Katsube M, Sakamoto M, Morimoto N. A Case of Giant Congenital Melanocytic Nevus Treated with Combination Therapy of Autologous Mesh-skin Grafts and Cultured Epithelial Autografts. Plastic and Reconstructive Surgery - Global Open 2021;9(6):e3613 View
- Morimoto N, Mitsui T, Sakamoto M, Mahara A, Yoshimura K, Arata J, Jinno C, Kakudo N, Kusumoto K, Yamaoka T. A Novel Treatment for Giant Congenital Melanocytic Nevi Combining Inactivated Autologous Nevus Tissue by High Hydrostatic Pressure and a Cultured Epidermal Autograft: First-in-Human, Open, Prospective Clinical Trial. Plastic & Reconstructive Surgery 2021;148(1):71e View
- Maletzki C, Freiin Grote V, Kalle F, Kleitke T, Zimpfer A, Becker A, Bergmann-Ewert W, Jonitz-Heincke A, Bader R, Vollmar B, Hackenberg S, Scherzad A, Mlynski R, Strüder D. Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction. Cell Death Discovery 2023;9(1) View
- Yamanaka H, Sawaragi E, Nakano T, Katayama Y, Ito T, Tada H, Hidaka Y, Morita S, Funakoshi C, Kinoshita A, Watanabe M, Tsuge I, Katsube M, Sakamoto M, Yamaoka T, Morimoto N. A high-hydrostatic pressure device for nevus tissue inactivation and dermal regeneration for reconstructing skin defects after giant congenital melanocytic nevus excision: a clinical trial. Regenerative Therapy 2023;24:167 View